Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000615233 | SCV000732140 | likely benign | not specified | 2017-02-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics Inc | RCV000711998 | SCV000842411 | benign | not provided | 2017-12-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000711998 | SCV001043381 | benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000615233 | SCV002068162 | likely benign | not specified | 2020-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404702 | SCV002707506 | likely benign | Maturity onset diabetes mellitus in young | 2019-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000711998 | SCV004563184 | likely benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing |